Journal of Respiratory Diseases invites high quality submissions that advance respiratory medicine, pulmonary science, and critical care practice. We welcome original research, systematic reviews, and methodological advances that improve diagnosis, management, and outcomes across respiratory diseases.

Our editorial focus prioritizes rigorous study design, transparent reporting, and translational relevance for clinical care and population health.

• Asthma, COPD, and airway inflammation
• Interstitial lung disease and pulmonary fibrosis
• Respiratory infections, pneumonia, and tuberculosis
• Sleep apnea and sleep related breathing disorders
• Critical care ventilation, ARDS, and respiratory failure
• Pulmonary hypertension and vascular lung disease
• Occupational and environmental respiratory exposures
• Pediatric respiratory disease and congenital airway disorders
• Thoracic imaging, biomarkers, and digital monitoring
• Lung cancer screening and early detection
• Smoking cessation, prevention, and population health
• Translational therapeutics, devices, and rehabilitation

• Clinical trial reports and interim analyses
• Short communications with high impact findings
• Case series with rigorous diagnostic criteria
• Practice or policy briefs grounded in evidence

Successful submissions present a clear clinical question, robust methodology, and transparent reporting of diagnostic and staging criteria. We value studies that connect mechanistic insights to patient outcomes or measurable clinical impact.

Authors should document cohort characteristics, pulmonary function tests, imaging protocols, and outcome definitions to support reproducibility and translation.

• Clear inclusion and exclusion criteria with disease staging
• Validated biomarkers, imaging parameters, or spirometry measures
• Appropriate statistical analysis and handling of confounders
• Interpretation that links findings to clinical decision making

Submissions undergo editorial screening for scope fit, methodological rigor, and reporting completeness. Qualified manuscripts move to single blind peer review with subject matter experts.

JRD operates under an open access model to ensure respiratory medicine research is discoverable and reusable. APCs are applied after acceptance and support peer review, production, and archiving services.

Membership options and affordable APC waivers are available for eligible authors. Contact the editorial office at [email protected] for guidance.

• Scope fit confirmed for respiratory medicine submissions
• Diagnostic and staging criteria documented
• Data availability statement included
• Ethics approvals and consent described
• Cover letter explains novelty and clinical relevance
• Report diagnostic criteria for asthma, COPD, ILD, or other respiratory conditions studied.
• Provide spirometry parameters (FEV1, FVC) with reference ranges and units.
• Describe bronchodilator response criteria and testing protocols when applicable.
• Include imaging modalities and acquisition parameters (X-ray, CT, HRCT, ultrasound).
• Report oxygenation metrics such as SpO2, PaO2, or PaO2/FiO2 ratios.
• Clarify exacerbation definitions and grading for respiratory disease severity.
• Describe microbiology sampling methods and antimicrobial susceptibility reporting.
• Detail medication exposure, dosing schedules, and adherence monitoring methods.
• Explain inclusion and exclusion criteria, comorbidities, and smoking history.
• Define adverse events, safety monitoring, and clinical endpoints clearly.
• Describe handling of missing data, confounders, and subgroup analyses.
• Provide data availability statements and access conditions for sensitive datasets.
• Document ethics approvals, informed consent, and biospecimen governance.
• Report pulmonary function tests, lung volumes, and diffusion capacity when relevant.
• Include model validation metrics and calibration details for predictive studies.
• State whether bronchoscopy or biopsy was used and provide rationale.
• Describe antiviral, anti-inflammatory, or biologic therapies and timelines.
• Provide baseline demographic tables with disease duration and comedications.
• Include biomarkers such as CRP, eosinophils, or IgE where relevant.
• Clarify ventilatory support settings and weaning protocols for ICU studies.
• Report imaging reader blinding, inter-rater reliability, or adjudication procedures.
• Describe quality control for laboratory assays and external proficiency testing.
• Include definitions for remission, response, progression, or relapse outcomes.
• Provide statistical power calculations or justification for sample size.
• Report secondary endpoints and exploratory analyses separately.
• Describe patient reported outcome measures and validation sources.
• State regulatory or trial registration identifiers when applicable.
• Provide statements on data sharing, reuse, and repository access.
• Explain limitations and generalizability for clinical implementation.
• Specify sample handling, storage temperatures, and processing timelines for biospecimens.
• Report comorbidity indices and medication interactions that may affect outcomes.
• Describe criteria for treatment response or nonresponse classifications.
• Include protocol for laboratory assay repeatability and inter-lab variation.
• Explain adjustments for confounders such as BMI, age, or smoking exposure.
• Provide patient flow diagrams and attrition details for each study stage.
• Include imaging scoring systems and threshold definitions used.
• Report hospitalization, mortality, or readmission outcomes when applicable.
• Clarify rationale for inclusion of control or comparator groups.
• Describe patient monitoring intervals and follow up adherence strategies.
• Explain criteria for noninvasive respiratory assessment and cutoff values.
• Provide details on imaging contrast agents, timing, and safety monitoring.
• Report surveillance intervals for high risk respiratory patients when relevant.
• Describe nutritional assessment methods and frailty measures when applicable.
• Include patient education or adherence interventions used in the study.
• Clarify definitions for acute versus chronic respiratory presentations.
• Describe criteria for hospitalization or readmission endpoints when measured.

JRD is committed to rigorous, transparent publishing in respiratory medicine and pulmonary science. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in respiratory and critical care research.